Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 10/20 | 0.42 |
| ▸ | HTR2A | P28223 | 7/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | HTR2B | P41595 | 2/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.30 |
| ▸ | AKT1 | P31749 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5636639 | 0.93 | HTR2C (0.48) | HTR2CHTR2AKMT2AMAPK1HTR2B | |
| SCHEMBL5636451 | 0.87 | HTR2C (0.51) | HTR2CHTR2AKMT2AMAPK1HTR2B | |
| SCHEMBL5636217 | 0.85 | HTR2C (0.40) | HTR2CHTR2AHTR2BDGAT1 | |
| SCHEMBL5637209 | 0.83 | HTR2C (0.42) | HTR2CHTR2AHTR2BAKT1 | |
| SCHEMBL5638526 | 0.83 | HTR2C (0.44) | HTR2CHTR2AHTR2BAKT1 | |
| SCHEMBL5635170 | 0.81 | HTR2C (0.46) | HTR2CHTR2AHTR2BAKT1 | |
| SCHEMBL5636624 | 0.81 | HTR2C (0.53) | HTR2CHTR2AHTR2B | |
| SCHEMBL5635940 | 0.80 | HTR2C (0.42) | HTR2CHTR2AHTR2B | |
| SCHEMBL5636363 | 0.79 | HTR2C (0.42) | HTR2CHTR2AHTR2B | |
| SCHEMBL5636801 | 0.79 | HTR2C (0.36) | HTR2CHTR2AHTR2BCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE39679-E1 | Substituted heterocycle fused gamma-carbolines | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-06-05 | — | — | US | disclosed |
| US-6713471-B1 | SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-30 | — | — | US | disclosed |